Liver Cirrhosis Research Today is a free monthly online journal that collates and summarizes the latest research about Liver Cirrhosis, including details on alcohol, treatment, drugs, effects, causes.

Volume 2 (2005), Issue 2 (February)

1. Genetic association of vitamin D receptor polymorphisms with autoimmune hepatitis and primary biliary cirrhosis in the Chinese.
   J Gastroenterol Hepatol, 20(2): 249-55. [Abstract] [Full-text]
2. Effect of liver cirrhosis on body composition: evidence of significant depletion even in mild disease.
   J Gastroenterol Hepatol, 20(2): 209-16. [Abstract] [Full-text]
3. Histopathology and clinical correlates of end-stage hepatitis B cirrhosis: a possible mechanism to explain the response to antiviral therapy.
   Liver Transpl, 11(1): 82-8. [Abstract] [Full-text]
4. Liver fibrosis.
   J Clin Invest, 115(2): 209-18. [Abstract] [Full-text]
5. Liver iron concentration and fibrosis in a cohort of transfusion-dependent patients on long-term desferrioxamine therapy.
   Hematol J, 5(7): 572-8. [Abstract] [Full-text]
6. Ursodeoxycholic acid reduces increased circulating endothelin 2 in primary biliary cirrhosis.
   Aliment Pharmacol Ther, 21(3): 227-34. [Abstract] [Full-text]
7. Long-term ursodeoxycholic acid therapy for primary biliary cirrhosis: a follow-up to 12 years.
   Aliment Pharmacol Ther, 21(3): 217-26. [Abstract] [Full-text]
8. Sterol parameters as markers of liver function in primary biliary cirrhosis before and after liver transplantation.
   Transpl Int, 18(2): 221-5. [Abstract] [Full-text]
9. Impact of steatosis on progression of fibrosis in patients with mild hepatitis C.
   Hepatology, 41(1): 82-7. [Abstract] [Full-text]
10. Genetic polymorphisms influencing xenobiotic metabolism and transport in patients with primary biliary cirrhosis.
    Hepatology, 41(1): 55-63. [Abstract] [Full-text]
11. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C.
    Hepatology, 41(1): 48-54. [Abstract] [Full-text]
12. Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases.
    Hepatology, 41(1): 40-7. [Abstract] [Full-text]
13. Serum sodium predicts mortality in patients listed for liver transplantation.
    Hepatology, 41(1): 32-9. [Abstract] [Full-text]
14. Biliary epithelial cells regulate autoreactive T cells: implications for biliary-specific diseases.
    Hepatology, 41(1): 151-9. [Abstract] [Full-text]
15. The effect of antiretroviral therapy on liver disease among adults with HIV and hepatitis C coinfection.
    Hepatology, 41(1): 123-31. [Abstract] [Full-text]
16. Activation of ubiquitin-proteasome pathway is involved in skeletal muscle wasting in a rat model with biliary cirrhosis: potential role of TNF-alpha.
    Am J Physiol Endocrinol Metab, 288(3): E493-501. [Abstract] [Full-text]
17. A Korean herbal medicine, Panax notoginseng, prevents liver fibrosis and hepatic microvascular dysfunction in rats.
    Life Sci, 76(15): 1675-90. [Abstract] [Full-text]
18. Effect of cirrhosis on antibiotic efficacy in a rat model of pneumococcal pneumonia.
    Diagn Microbiol Infect Dis, 51(2): 103-11. [Abstract] [Full-text]
19. Combination of interferon-beta and angiotensin-converting enzyme inhibitor, perindopril, attenuates the murine liver fibrosis development.
    Liver Int, 25(1): 153-61. [Abstract] [Full-text]
20. Nitric oxide synthases inhibition results in renal failure improvement in cirrhotic rats.
    Liver Int, 25(1): 131-40. [Abstract] [Full-text]
21. Raloxifene improves bone mass in osteopenic women with primary biliary cirrhosis: results of a pilot study.
    Liver Int, 25(1): 117-21. [Abstract] [Full-text]
22. Outcome after orthotopic liver transplantation in five HIV-infected patients with virus hepatitis-induced cirrhosis.
    Liver Int, 25(1): 101-8. [Abstract] [Full-text]
23. The influence of spleen size on liver regeneration after major hepatectomy in normal and early cirrhotic liver.
    Liver Int, 25(1): 96-100. [Abstract] [Full-text]
24. In vivo expression patterns of survivin and its splicing variants in chronic liver disease and hepatocellular carcinoma.
    Liver Int, 25(1): 77-84. [Abstract] [Full-text]
25. Increasing frequency of Gram-positive bacteria in spontaneous bacterial peritonitis.
    Liver Int, 25(1): 57-61. [Abstract] [Full-text]
26. Hemosiderosis is associated with accelerated decompensation and decreased survival in patients with cirrhosis.
    Liver Int, 25(1): 41-8. [Abstract] [Full-text]
27. Elevated plasma adiponectin concentrations in patients with liver cirrhosis correlate with plasma insulin levels.
    Liver Int, 25(1): 28-32. [Abstract] [Full-text]
28. Which patients with primary biliary cirrhosis or primary sclerosing cholangitis should undergo endoscopic screening for oesophageal varices detection?
    Gut, 54(3): 407-10. [Abstract] [Full-text]
29. Association of Helicobacter species with hepatitis C cirrhosis with or without hepatocellular carcinoma.
    Gut, 54(3): 396-401. [Abstract] [Full-text]
30. Markers of cell activation and apoptosis in bone marrow mononuclear cells of patients with autoimmune hepatitis type 1 and primary biliary cirrhosis.
    J Hepatol, 42(3): 393-9. [Abstract] [Full-text]
31. Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis.
    J Hepatol, 42(3): 386-92. [Abstract] [Full-text]
32. Autoimmune cholestatic liver disease in people with coeliac disease: a population-based study of their association.
    Aliment Pharmacol Ther, 21(4): 401-5. [Abstract] [Full-text]
33. Human leukocyte antigen class II alleles in Caucasian women with primary biliary cirrhosis.
    Tissue Antigens, 65(2): 199-205. [Abstract] [Full-text]
34. Fibrosis heterogeneity in nonalcoholic steatohepatitis and hepatitis C virus needle core biopsy specimens.
    Am J Clin Pathol, 123(3): 382-7. [Abstract] [Full-text]
35. Effect of cirrhosis and liver transplantation on the gender difference in QT interval.
    Am J Cardiol, 95(5): 691-4. [Abstract] [Full-text]
36. Indications of partial hepatectomy for transplantable hepatocellular carcinoma with compensated cirrhosis.
    Am J Surg, 189(2): 167-72. [Abstract] [Full-text]
37. Impact of interferon-alpha therapy on liver fibrosis progression in patients with HBeAg-negative chronic hepatitis B.
    J Viral Hepat, 12(2): 199-206. [Abstract] [Full-text]
38. Comparison between handgrip strength, subjective global assessment, and prognostic nutritional index in assessing malnutrition and predicting clinical outcome in cirrhotic outpatients.
    Nutrition, 21(2): 113-7. [Abstract] [Full-text]
39. Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis.
    Hepatology, 41(2): 307-14. [Abstract] [Full-text]
40. Improving the prediction of hepatocellular carcinoma in cirrhotic patients with an arterially-enhancing liver mass.
    Liver Transpl, 11(3): 281-9. [Abstract] [Full-text]
41. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone.
    Liver Transpl, 11(3): 336-43. [Abstract] [Full-text]
42. Frequent cellular senescence in small bile ducts in primary biliary cirrhosis: a possible role in bile duct loss.
    J Pathol, 205(4): 451-9. [Abstract] [Full-text]
43. A side effect of neuraminidase inhibitor in a patient with liver cirrhosis.
    J Infect Chemother, 11(1): 41-3. [Abstract] [Full-text]
44. Clinical laboratory assessment of hepatitis C and HIV coinfected patients according to the antiretroviral therapy received.
    Rev Inst Med Trop Sao Paulo, 47(1): 13-7. [Abstract] [Full-text]
45. Perfusion imaging of the liver: current challenges and future goals.
    Radiology, 234(3): 661-73. [Abstract] [Full-text]
46. The Western immunoblotting pattern of anti-mitochondrial antibodies is independent of the clinical expression of primary biliary cirrhosis.
    Dig Liver Dis, 37(2): 108-12. [Abstract] [Full-text]
47. Hyponatremia in liver cirrhosis: pathophysiological principles of management.
    Dig Liver Dis, 37(2): 73-81. [Abstract] [Full-text]
48. Improvement of portal hypertension and hepatic blood flow in cirrhotic rats by oestrogen.
    Eur J Clin Invest, 35(3): 220-5. [Abstract] [Full-text]
49. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests.
    Hepatology, 41(3): 553-8. [Abstract] [Full-text]
50. No relevant effect of ursodeoxycholic acid on cytochrome P450 3A metabolism in primary biliary cirrhosis.
    Hepatology, 41(3): 595-602. [Abstract] [Full-text]
51. Patients with cirrhosis and bare-stent TIPS may have increased risk of hepatocellular carcinoma.
    Hepatology, 41(3): 566-71. [Abstract] [Full-text]
52. Small ubiquitin-related modifiers: A novel and independent class of autoantigens in primary biliary cirrhosis.
    Hepatology, 41(3): 609-16. [Abstract] [Full-text]
53. Survival and intra-hepatic recurrences after laparoscopic radiofrequency of hepatocellular carcinoma in patients with liver cirrhosis.
    J Surg Oncol, 89(4): 218-25; discussion 225-6. [Abstract] [Full-text]
54. Effects of celecoxib and naproxen on renal function in nonazotemic patients with cirrhosis and ascites.
    Hepatology, 41(3): 579-87. [Abstract] [Full-text]
55. Bacterial translocation (BT) in cirrhosis.
    Hepatology, 41(3): 422-33. [Abstract] [Full-text]
56. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation.
    Radiology, 234(3): 961-7. [Abstract] [Full-text]

© 2004-2008 Liver Cirrhosis Research Today. All Rights Reserved.